• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
National Estimates and Physician-Reported Impacts of Prescription Drug Monitoring Program Use.全国范围内的预估数据以及医生报告的处方药物监测项目的使用影响。
J Gen Intern Med. 2023 Mar;38(4):881-888. doi: 10.1007/s11606-022-07793-x. Epub 2022 Oct 13.
2
Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).医生对马里兰州处方药监测计划(PDMP)的态度和经历。
Addiction. 2017 Feb;112(2):311-319. doi: 10.1111/add.13620. Epub 2016 Nov 3.
3
Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.州级处方药物监测计划(PDMP)要求与医生为非癌症慢性疼痛患者开具阿片类镇痛药处方模式之间的关联。
Addict Behav. 2018 Jan;76:348-354. doi: 10.1016/j.addbeh.2017.08.032. Epub 2017 Sep 5.
4
Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.医生对退伍军人事务部处方药物监测计划使用的看法:一项多州定性研究。
J Gen Intern Med. 2018 Aug;33(8):1253-1259. doi: 10.1007/s11606-018-4374-1. Epub 2018 Mar 8.
5
The association between prescription drug monitoring programs and controlled substance prescribing: a cross-sectional study using data from 2019 National Electronic Health Records Survey.处方药物监测计划与管制物质处方之间的关联:使用 2019 年国家电子健康记录调查数据的横断面研究。
J Am Med Inform Assoc. 2023 May 19;30(6):1042-1046. doi: 10.1093/jamia/ocad053.
6
Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.利用处方药物监测计划进行处方和配药决策:一项多地点定性研究的结果。
Res Social Adm Pharm. 2019 Jun;15(6):754-760. doi: 10.1016/j.sapharm.2018.09.007. Epub 2018 Sep 14.
7
Characteristics of state prescription drug monitoring programs: a state-by-state survey.州处方药监测项目的特点:一项逐州调查
Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):847-51. doi: 10.1002/pds.4003. Epub 2016 Apr 8.
8
Effect of Integrating Access to a Prescription Drug Monitoring Program Within the Electronic Health Record on the Frequency of Queries by Primary Care Clinicians: A Cluster Randomized Clinical Trial.电子病历中整合处方药物监测项目对初级保健临床医生查询频率的影响:一项整群随机临床试验。
JAMA Health Forum. 2022 Jun 5;3(6):e221852. doi: 10.1001/jamahealthforum.2022.1852. eCollection 2022 Jun.
9
Prescription Drug Monitoring Program Use: National Dental PBRN Results.处方药监测计划的使用:全国牙科初级保健研究网络的结果。
JDR Clin Trans Res. 2019 Apr;4(2):178-186. doi: 10.1177/2380084418808517. Epub 2018 Oct 29.
10
Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.2012 年,全国范围内的医学毒理学家对处方药物监测计划(PDMP)的处方实践、知识和使用情况进行了调查。
J Med Toxicol. 2012 Dec;8(4):341-52. doi: 10.1007/s13181-012-0250-2.

引用本文的文献

1
Healthcare professionals' perceptions of electronic prescription systems in outpatient services: a qualitative study at UNS hospital.医疗保健专业人员对门诊电子处方系统的看法:在UNS医院进行的一项定性研究
Cost Eff Resour Alloc. 2025 Jun 18;23(1):31. doi: 10.1186/s12962-025-00639-3.

本文引用的文献

1
Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis.医疗保健提供者对处方监测计划的利用:系统评价和荟萃分析。
Pain Med. 2021 Jul 25;22(7):1570-1582. doi: 10.1093/pm/pnaa412.
2
Barriers and facilitators to PDMP IS Success in the US: A systematic review.美国 PDMP IS 成功的障碍和促进因素:系统评价。
Drug Alcohol Depend. 2021 Feb 1;219:108460. doi: 10.1016/j.drugalcdep.2020.108460. Epub 2020 Dec 19.
3
Polysubstance abuse associated with more frequent opioid use among patients in rural primary care settings.在农村基层医疗环境中,多物质滥用与患者更频繁使用阿片类药物相关。
J Opioid Manag. 2020 Jul/Aug;16(4):283-289. doi: 10.5055/jom.2020.0582.
4
Opioids, Polypharmacy, and Drug Interactions: A Technological Paradigm Shift Is Needed to Ameliorate the Ongoing Opioid Epidemic.阿片类药物、多药合用与药物相互作用:需要技术范式转变来缓解持续的阿片类药物流行。
Pharmacy (Basel). 2020 Aug 25;8(3):154. doi: 10.3390/pharmacy8030154.
5
The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review.处方药物监测项目在减少阿片类药物相关危害和后果方面的有效性:系统评价。
BMC Health Serv Res. 2019 Nov 1;19(1):784. doi: 10.1186/s12913-019-4642-8.
6
Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review.医源性阿片类药物使用障碍、慢性疼痛和精神共病:系统评价。
Gen Hosp Psychiatry. 2019 Jul-Aug;59:37-50. doi: 10.1016/j.genhosppsych.2019.04.008. Epub 2019 Apr 25.
7
Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.强制性处方药物监测计划(PDMP)使用法规对开方者登记和使用以及高风险处方的影响。
Drug Alcohol Depend. 2019 Jun 1;199:1-9. doi: 10.1016/j.drugalcdep.2019.02.010. Epub 2019 Mar 22.
8
Perception of prescription drug monitoring programs as a prevention tool in primary medical care.将处方药监测项目视为初级医疗保健中的一种预防工具。
Res Social Adm Pharm. 2020 Sep;16(9):1306-1308. doi: 10.1016/j.sapharm.2019.03.012. Epub 2019 Mar 26.
9
Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse.强制性访问处方药物监测计划与处方药物滥用
J Policy Anal Manage. 2019;38(1):181-209.
10
Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions.评估州级处方药物监测计划政策对高危阿片类药物处方的影响。
Health Aff (Millwood). 2018 Oct;37(10):1596-1604. doi: 10.1377/hlthaff.2018.0512.

全国范围内的预估数据以及医生报告的处方药物监测项目的使用影响。

National Estimates and Physician-Reported Impacts of Prescription Drug Monitoring Program Use.

机构信息

Office of Technology, Office of the National Coordinator for Health Information Technology, Washington, DC, USA.

出版信息

J Gen Intern Med. 2023 Mar;38(4):881-888. doi: 10.1007/s11606-022-07793-x. Epub 2022 Oct 13.

DOI:10.1007/s11606-022-07793-x
PMID:36229762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10039204/
Abstract

BACKGROUND

Despite widespread adoption of state prescription drug monitoring programs (PDMPs), it is unclear how often PDMPs are accessed through an electronic health record system (EHR-PDMP integration), or whether efforts to make PDMPs easier to access and use have improved their utility.

OBJECTIVE

To produce national-level estimates on the use of PDMPs among office-based physicians and benefits associated with their use.

DESIGN

We use nationally representative survey data to produce descriptive statistics on PDMP use and associated benefits among office-based physicians in the USA.

PARTICIPANTS

1398 office-based physicians who prescribe controlled substances.

MAIN MEASURES

We examined physician-reported ease and frequency of PDMP use, and how EHR-PDMP integration affects frequency and ease of use. Multivariate models were used to assess whether characteristics of PDMP use were related to physician-reported benefits such as reduced prescribing of controlled substances and perceived improvements in clinical decision-making.

KEY RESULTS

In 2019, two-thirds of office-based physicians in the USA reported frequent use of their state PDMP and over three-quarters reported they were easy to use. Both frequency and ease of use were positively correlated with PDMP integration status. Respondents who frequently checked their state's PDMP were 8.7 percentage points (95% CI -.4 to 17.8) more likely to report perceived benefits and reported 2.2 (95% CI 1.54 to 2.83) more benefits. Respondents who indicated their PDMP was easy to use were 12.7 percentage points (95% CI .040 to .214) more likely to report perceived benefits and reported 0.94 (95% CI 0.26 to 1.61) more benefits.

CONCLUSIONS

Our findings suggest efforts to make PDMPs easier to access and use aided physicians in making informed clinical decisions that may not be captured by reduced prescribing alone. Efforts to further increase frequency and ease of use-including advancing a standards-based approach to PDMP and EHR data interoperability-may further increase the benefit of PDMPs.

摘要

背景

尽管州级处方药物监测计划(PDMP)已被广泛采用,但 PDMP 通过电子健康记录系统(EHR-PDMP 集成)的访问频率尚不清楚,也不清楚使 PDMP 更易于访问和使用的努力是否提高了它们的实用性。

目的

生成关于美国门诊医生使用 PDMP 的全国性估计数据,并评估与之相关的益处。

设计

我们使用全国代表性调查数据生成美国门诊医生使用 PDMP 的描述性统计数据以及与之相关的益处。

参与者

1398 名开处受控物质的门诊医生。

主要措施

我们检查了医生报告的 PDMP 使用的便利性和频率,以及 EHR-PDMP 集成如何影响使用的频率和便利性。使用多变量模型评估 PDMP 使用的特征是否与医生报告的益处相关,例如减少开具受控物质的处方和认为临床决策有所改善。

主要结果

在 2019 年,美国有三分之二的门诊医生报告经常使用其所在州的 PDMP,超过四分之三的医生报告 PDMP 易于使用。使用的频率和便利性均与 PDMP 集成状态呈正相关。经常检查所在州 PDMP 的受访者更有可能报告认为有收益,且报告的收益多 8.7 个百分点(95%CI -.4 至 17.8)。表示 PDMP 易于使用的受访者更有可能报告认为有收益,且报告的收益多 12.7 个百分点(95%CI.040 至.214)。

结论

我们的研究结果表明,使 PDMP 更易于访问和使用的努力有助于医生做出知情的临床决策,而这些决策可能不仅仅通过减少处方来实现。进一步增加 PDMP 的使用频率和便利性的努力——包括推进基于标准的 PDMP 和 EHR 数据互操作性——可能会进一步提高 PDMP 的益处。